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1. Introduction 
Dopamine /3-hydroxylase (EC 1.14.2.1) is a tetrameric 
glycoprotein with a subunit mol. wt 75 000, and a 
carbohydrate content of -4% [ 1,2]. It is present in 
catecholamine storage vesicles of both adrenal medulla 
and sympathetic nerve terminals, where it catalyzes 
the biosynthesis of norepinephrine from dopamine. 
Approximately equal amounts of the enzyme occur in 
soluble and membrane-bound forms in adrenal chromaf- 
fin granules [3], whereas most of the dopamine /3-hydrox- 
ylase in large, dense-cored sympathetic nerve vesicles 
is soluble [4]. Dopamine /3-hydroxylase is also present 
in the plasma [5] due to its release by exocytosis from 
storage organelles. 
The soluble and membrane-bound forms of the 
enzyme isolated from adrenal chromaffin granules 
appear to be identical in many respects [3] including 
their carbohydrate composition [2], and it has been 
reported that enzymatic removal of 4 of the 7 mannose 
residues present in the dopamine fl-hydroxylase 
monomer does not result in the loss of any catalytic 
activity [6]. Therefore, in spite of the extensive inter- 
est from a number of standpoints in this key enzyme 
in catecholamine biosynthesis, the function of its car- 
bohydrate moiety is presently unknown. 
There is, however, recent evidence that glycosyla- 
tion decreases the sensitivity of certain proteins to 
proteolytic degradation [7,8]. It has also been reported 
that mild trypsin treatment of the soluble proteins 
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from adrenal chromaffin granules resulted in the rapid 
degradation of the chromogranins, whereas dopamine 
/3-hydroxylase survived this mild proteolysis without 
change in affinity for tyramine, loss of immunoreac- 
tivity or change in electrophoretic mobility [9]. Since 
the carbohydrate moiety may serve to protect it from 
proteolytic degradation, we have examined the effect 
of enzymatic deglycosylation on the susceptibility of 
dopamine /3-hydroxylase to tryptic proteolysis. 
2. Experimental 
Chromaffin granules were isolated from bovine 
adrenal medullae by differential centrifugation fol- 
lowed by a simplified sucrose density gradient [IO] 
modified as in [2]. The granules obtained from 20 
adrenals were lysed by homogenizing in 90 ml 5 mM 
Tris-sodium succinate buffer (pH 5.9) followed by 
freezing and thawing. The suspension was then cen- 
trifuged for 1 h at 190 000 X g, the pellet rehomoge- 
nized in 90 ml buffer, and the freezing, thawing and 
centrifugation steps repeated as above. The combined 
supernatants were either dialyzed against deionized 
water and lyophilized for the large-scale isolation of 
dopamine &hydroxylase and other soluble granule 
proteins, or the supernatant resulting from the initial 
lysis step was used directly for ion-exchange chroma- 
tography and measurement of enzyme activity [ 111. 
The soluble chromaffin granule proteins were dis- 
solved (at -3 mg/ml) in 50 mM Tris-HCl buffer 
(pH 8.2 at 4°C) containing 90 mM NaCl. This was 
then applied to a column of DEAE-cellulose (Whatman 
DE-52) equilibrated with the same buffer. The first of 
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the 3 peaks eluted at this [NaCl] contained all of the 
dopamine /3-hydroxylase activity, and migrated as a 
single Coomassie Blue-stained band (with a subunit 
mol. wt 73 000) in 7% SDS-polyacrylamide gels 
[ 121, or in 6% polyacrylamide gels using a Tris-glycine 
buffer system [ 131. The chromogranins and two spe- 
cies of chondroitin sulfate proteoglycans [ 141 were 
later eluted from the DEAE-cellulose column using 
higher [NaCl]. 
Dopamine /3-hydroxylase (DBH), at 10 mg/ml, was 
incubated for 8 h at 37°C with Vibrio cholerae neura- 
minidase (13.5 units/mg DBH) in 50 mM sodium ace- 
tate buffer (pH 6.0) containing 0.15 M NaCl and 
5 mM CaC12. The incubation mixture was then dia- 
lyzed for 2 days against 2 changes (100 vol. each) of 
distilled water at 4”C, and lyophilized. 
In some experiments the DBH was first treated (in 
the pH 6 buffer) with both neuraminidase and rat 
epididymis L-a-fucosidase (0.0 12 units/mg), and after 
dialysis the lyophilized material was redissolved at the 
original concentration in 50 mM sodium citrate buffer 
(pH 4.5) for a further 8 h incubation at 37°C with 
Jack Bean /3-galactosidase (0.026 units/mg), /3-N-acetyl- 
glucosaminidase (0.05 units/mg) and a-mannosidase 
(0.18 units/mg). 
Sialic acid was determined by the periodate-resor- 
cinol method [ 151 and glucosamine was determined 
using the amino acid analyzer (after deacetylation in 
2 N HCl for 3 h at lOO”C, in the case of N-acetyl- 
glucosamine released by glycosidase treatment). Man- 
nose, galactose and fucose were assayed by automated 
ion-exchange chromatography of their borate com- 
plexes [ 161 using a gradient containing 100 ml each of 
0.27 M sodium borate buffer (pH 7.7) and 0.4 M borate 
buffer (pH 10) with a 0.3 X 70 cm column of Hamil- 
ton HA X 6 resin. The neutral sugar concentration of 
the original DBH sample was determined after hydro- 
lysis for 3 h in 2 N trifluoroacetic acid at lOO”C, and 
amino sugars were determined after hydrolysis for 
22 h in 6 N HCl at 110°C (with correction for destruc- 
tion during hydrolysis). 
The glycosidase-treated DBH was incubated with 
trypsin for varying times at 37°C in 20 mM Tris-HCl 
buffer (pH 7.5) containing 3.6 mM CaCl*. The tryptic 
digestion was terminated by the addition of soybean 
trypsin inhibitor in a ratio of 2.5 mg inhibitor/mg 
trypsin. 
Neuraminidase was obtained from Behringwerke/ 
Calbiochem. All other enzymes and soybean trypsin 
inhibitor were purchased from Sigma, St Louis, MO. 
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3. Results and discussion 
Treatment of dopamine P-hydroxylase with neura- 
minidase, L-a-fucosidase, fl-galactosidase, P-N-acetyl- 
glucosaminidase, and ol-mannosidase under optimum 
conditions released >90% of the sialic acid but <20% 
of the fucose or other (mostly internal) sugar residues. 
The resistance of intact glycoproteins, as compared to 
glycopeptides, to enzymatic deglycosylation is a well- 
known phenomenon, and was therefore not unexpected 
in this case. However, 24-48 h incubation with an 
cw-mannosidase of unspecified origin removed over 
half of the mannose residues from DBH without prior 
or concomitant treatment with any other glycosidases 
[6], suggesting that many of the mannose residues are 
present in terminal positions, or that their enzyme 
preparation was contaminated with other glycosidase 
activities. 
Dopamine fl-hydroxylase treated with neurami- 
nidase alone or neuraminidase followed by other glyco- 
sidases migrated on polyacrylamide gels as a single band 
with the same mobility as untreated DBH (fig.1). 
However, whereas the original DBH was largely resis- 
tant to trypsin proteolysis, as in [9], desialylated DBH 
was almost completely degraded. Shorter periods of 
incubation or lower ratios of trypsin to desialylated 
DBH resulted in less digestion of the DBH but did not 
produce degradation products having a greater elec- 
trophoretic mobility. The slight effect of trypsin on 
‘native’ DBH before treatment with neuraminidase 
can probably be attributed to an action on those 
molecules lacking their full complement of sialic acid 
residues, in agreement with the known microhetero- 
geneity of glycoproteins. 
The oligosaccharide structure of glycoproteins 
may be of considerable importance in determining 
their biological activities. In other cases the carbohy- 
drate moiety appears to function as a signal for the 
secretion of certain proteins, or for their recognition 
and/or uptake by cells and tissues. The extensive 
studies of Ashwell, Morel1 and coworkers (reviewed in 
reference [ 171) indicate a generalized role for the ter- 
minal sialic acid residues of circulating glycoproteins. 
These investigations have demonstrated that terminal 
galactose residues, exposed by enzymatic removal of 
sialic acid, constitute a structural configuration recog- 
nizable by receptors present on hepatocyte plasma 
membranes, and capable of initiating prompt clearance 
and catabolism of such asialoglycoproteins. However, 
in the case of many proteins the functional significance 
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Fig. 1. Polyacrylamide gel electrophoresis in Tris-glycine 
buffer of: (A) 30 pg dopamine p-hydroxylase; (B) 30 pg DBH 
incubated for 6 h with 3 pg trypsin; (C) 30 c1g desialylated 
DBH incubated for 6 h;(D) 30 pg desialylated DBH incubated 
for 6 h with 3 pg trypsin; (E) 3 tig trypsin plus soybean trypsin 
inhibitor. Incubation and electrophoresis conditions were as 
in section 2. 
of glycosylation is unknown. 
The studies reported here demonstrate that the 
presence of sialic acid residues greatly increases the 
resistance of dopamine /3-hydroxylase to tryptic pro- 
teolysis. This may be a general function of glyco- 
sylation in many glycoproteins. The addition of carbo- 
hydrates at the p-turns of proteins was proposed to 
result in the masking of the turn conformations [ 181, 
and could therefore be an important factor in protect- 
ing the molecule from proteolysis. It was later shown 
that inhibition of glycosylation does not affect the 
biosynthesis or secretion of the common precursor to 
ACTH and/3-lipoprotein, but did result in an enhanced 
proteolysis of the unglycosylated precursor, and its 
processing to a set of atypical peptides which were 
secreted by the pituitary [7]. It has also been reported 
[8] that inhibition of glycosylation of fibronectin, a 
major cell surface glycoprotein, did not affect its syn- 
thesis, secretion or biological activity, but greatly 
increased its sensitivity to proteolysis. These reports, 
together with these findings concerning dopamine 
fi-hydroxylase, support the concept that in many glyco- 
proteins the carbohydrate moiety may serve to inhibit 
proteolytic degradation. In the case of dopamine 
fl-hydroxylase it is apparently only the terminal sialic 
acid residues which are required for this effect, a situ- 
ation analogous to the specific role of sialic acid in 
regulating the circulation time of serum glycoproteins 
[ 171. Our data also provide the first indication con- 
cerning the functional role of sugar residues in this 
central enzyme of catecholamine metabolism. 
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